Press Releases

AdvaMed: VALID Act an “Important Step Toward the Long-Overdue Modernization” of Law Governing Diagnostic Tests

WASHINGTON, D.C. – AdvaMed President and CEO Scott Whitaker and AdvaMedDx Executive Director Susan Van Meter issued the following statements upon re-introduction today in the House and Senate of the Verifying Accurate, Leading-edge IVCT Development (VALID) Act for regulatory oversight of in vitro clinical tests (IVCTs) – including in vitro diagnostics (IVDs) and laboratory-developed tests (LDTs):

“The bipartisan VALID Act is an important step toward the long-overdue modernization of the law for all diagnostic tests. It calls for smart reforms that will incentivize and improve the development of the advanced, reliable tests patients depend on, regardless of where those tests were developed,” said Scott Whitaker, president and CEO of AdvaMed. “We thank Senators Michael Bennet (D-Colo.) and Richard Burr (R-N.C.) and Reps. Diana DeGette (D-Colo.) and Larry Bucshon (R-Ind.)  for their leadership and we look forward to working with them on this important bill.”

“IVCTs are advancing more quickly than ever, leading to increasingly rapid identification of disease, informing the right treatments for the right patients, and serving as the foundation of personalized medicine that holds great promise,” said Susan Van Meter, executive director of AdvaMedDx. “COVID has underscored the necessity of clarity of oversight and transparency for all clinical tests.  This legislation would allow patients and their clinicians to have the confidence they need that innovative diagnostics of the highest standards will be available to them across the health care delivery system. We thank the bipartisan sponsors of the VALID Act for their leadership in introducing this legislation. We look forward to working with them and our partners in the patient, provider and laboratory community to make innovative diagnostics regulatory reform a reality.”

# # #

 AdvaMed member companies produce the medical devices, diagnostic products and health information systems that are transforming health care through earlier disease detection, less invasive procedures and more effective treatments. AdvaMed members range from the largest to the smallest medical technology innovators and companies. For more information, visit